- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00676858
Gas Embolism With Use of Argon Plasma Coagulation
March 24, 2017 updated by: Adnan Majid, Beth Israel Deaconess Medical Center
The purpose of this study is to use transesophageal echocardiography (TEE) to determine the incidence, severity, and clinical significance of gas bubbles during argon plasma coagulation (APC).
Study Overview
Status
Completed
Conditions
Detailed Description
Gas embolism is a rare but serious complication of APC.
We will use TEE to monitor for gas bubbles during APC.
APC will be terminated if gas bubbles are associated with ischemic heart rhythms, wall motion abnormalities, or if large gas bubbles are noted in the left ventricle.
Study Type
Observational
Enrollment (Actual)
42
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Beth Israel Deaconess Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients referred to tertiary care center
Description
Inclusion Criteria:
- Adults (male and female) 18 years of age or older
- Clinical indication for bronchoscopy (hemoptysis, airway obstruction, tumor excision, granulation tissue that is impairing endobronchial stent performance)
- Ability of the patient or proxy to read, comprehend, and sign informed consent document.
Exclusion Criteria:
- Presence of esophageal disorders that may complicate transesophageal echocardiography (strictures, varices, fistula, prior esophageal surgery)
- Presence of coagulopathy or other bleeding diathesis
- Inability to tolerate brief periods of apnea
- Presence of pulmonary vascular disease
- Pregnant women will not be included in this study because the potential fetal hypoxemia is not an acceptable risk.
- No exclusions will be made based on gender or race.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
incidence of gas bubbles with use of APC
Time Frame: end of procedure
|
end of procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Adnan Majid, MD, Beth Israel Deaconess Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2008
Primary Completion (Actual)
July 5, 2011
Study Completion (Actual)
July 5, 2011
Study Registration Dates
First Submitted
May 9, 2008
First Submitted That Met QC Criteria
May 12, 2008
First Posted (Estimate)
May 13, 2008
Study Record Updates
Last Update Posted (Actual)
March 28, 2017
Last Update Submitted That Met QC Criteria
March 24, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2008P000124
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
IPD was not shared
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Embolism, Air
-
ClearLine MDCompletedAir Leakage | Air Embolism | Air Burden
-
University of NebraskaCompletedAir Embolism as A Complication of Medical CareUnited States
-
Petronella TorildCompletedExtracorporeal Circulation; Complications | Air EmbolismSweden
-
Umeå UniversityRecruitingHemodialysis Complication | Extracorporeal Circulation; Complications | Air EmbolismSweden
-
Meshalkin Research Institute of Pathology of CirculationUnknownAir Embolism | Neurological DamageRussian Federation
-
University Hospital, MontpellierCompletedPatients Who Underwent Percutaneous Lung Biopsy Under CT Guidance | Patients Who Presented Systemic Air Embolism After Percutaneous Lung Biopsy Under CT Guidance Depicted at the Time of the Procedure on a Whole Thoracic CTFrance
-
Cardiochirurgia E.H.Completed
-
Lund UniversityCompletedBrain Ischemia | Reduction of Cerebral Air EmboliSweden
-
University Hospital, Basel, SwitzerlandCompletedProlonged Air Leak | Postoperative Air LeakSwitzerland
-
Hannover Medical SchoolTerumo Europe N.V.; Städtisches Klinikum BraunschweigUnknownCoronary Artery Disease | Embolism, Air | Intracranial Embolism | Acute Cerebrovascular AccidentGermany